T he regulation of blood flow requires immediate adjustments in the diameter of small arteries and arterioles to satisfy the metabolic demand of distal tissues. This phenomenon is pressure sensitive and maintains blood flow despite fluctuations in perfusion pressure. Bayliss 1 first observed that stretch imposed on the vascular wall by intravascular pressure mediates a contractile or a myogenic response. A rise in the cytosolic Ca 2+ concentration ([Ca 2+ ]) in vascular smooth muscle cells (VSMCs) contributes to this response and generally is attributed to depolarization-induced activation of L-type Ca 2+ (Ca v 1.2) channels, Ca 2+ influx, and myogenic vasoconstriction according to wall tension. 2-8 Several ion channels have been implicated in stretch-induced depolarization including cationconducting channels (transient receptor potential channel 6 [TRPC6]/transient receptor potential cation channel, subfamily M, member 4 [TRPM4]) 2-4 and voltage-gated K + (K v ) channels encoded by the K v 7 gene family (KCNQ). 5-7 These channels exhibit only modest mechanosensitivity in heterologous
expression systems, [8] [9] [10] suggesting that they are not the primary mechanosensors responsible for myogenic vasoconstriction.
Osmotically induced cell stretch was reported to initiate a conformational switch in angiotensin II (Ang II) type 1 receptor (AT 1 R) during which transmembrane (TM) segment 7 enters the ligand-binding pocket to cause activation. 8 Apparently the stretch-induced disruption of interhelical interactions between TM 7 and other TM that stabilize AT 1 R in an inactive state enables TM 7 to enter the ligand-binding pocket of AT 1 R to activate it independently of Ang II. 8 Initial reports also raise the possibility that multiple mechanosensitive G protein-coupled receptors (GPCRs), including AT 1 R, contribute to myogenic responsiveness through ligand-independent signaling and G q/11 -protein activation of TRPC6 channels. 11 Overexpression of vasoconstrictor GPCRs conferred mechanosensitivity that relied on TRPC6 channel activation, 11 but this pathway defined in heterologous systems may relate to protein overexpression and may not represent a native feature of VSMCs. In addition, osmotic challenge as a way of mimicking pressure-induced stretch may substantially change intracellular signaling by various molecules, which is not representative of their function in native cells.
Thus, a definitive role for AT 1 R subtype a (AT 1a R) and other GPCRs as ligand-independent mechanosensors in VSMCs has not been firmly established, and the downstream effectors that mediate stretch-induced depolarization are unknown. For example, AT 1 R antagonism with losartan or candesartan does not inhibit myogenic tone in rat mesenteric arteries (MAs) 12, 13 and only mildly blunts myogenic tone in rat cerebral arteries. 11 Furthermore, a recent study questioned if the interaction between uridine 5′-triphosphate-activated G q/11 protein and TRPC-like currents contributes to the development of myogenic tone in rat cerebral resistance arteries. 14 As an alternative mechanism for myogenic responsiveness, AT 1 R activation was described to suppress K v channels via G q/11 -dependent activation of protein kinase C-interacting proteins, thereby increasing the contractile response to Ang II. 15 The additonal observation that XE991-sensitive K v channels buffer myogenic vasoconstriction 5 suggests that suppression of KCNQ-type channels by GPCRs is a previously unrecognized mechanism for stretchinduced depolarization and myogenic tone. 16 Indeed, AT 1 R activation inhibits cloned KCNQ2/3 channels in heterologous expression via phosphatidylinositol 4,5-bisphosphate depletion, 17 and KCNQ transcripts are found in small arteries. [5] [6] [7] Interestingly, native KCNQ2/3 heteromeric channels that show sensitivity to pharmacological block by XE991 18 are inhibited by G q -dependent phosphatidylinositol 4,5-bisphosphate depletion, 19, 20 an event implicated in GPCR-initiated myogenic tone.
Here, we explored mechanisms of mechanosensitive AT 1a R signaling in VSMCs. Because myogenic responsiveness in vivo is modulated by perfusion pressure and blood flow 21 and these factors differ between vascular beds, our studies included both pressurized MAs and isolated perfused kidneys to assess regulatory pathways of myogenic tone. We compared arterial myogenic responses between wild-type (WT) mice and mutant mice with deletion of genes coding for the AT 1a R (Agtr1a −/− mice) and angiotensinogen (Agt −/− mice) to evaluate conclusively whether AT 1a R are Ang II-independent mechanosensors in VSMCs. Mice with deletion or modification of genes encoding TRPC6 and KCNQ3, 4, and 5 channels were used to explore the role of these channels as downstream effectors of AT 1a R-initiated myogenic signaling. Collectively, our results provide the first definitive analysis to pinpoint the AT 1a R as the major AT 1 receptor subtype that can elicit myogenic constriction of mesenteric and renal resistance arteries in the absence of its native ligand, Ang II. Interestingly, we failed to confirm TRPC6 channels as a target of AT 1a R mechanosensing, although earlier studies implicated them as obligatory components of the myogenic response. Instead, our findings revealed that a previously unrecognized XE991-sensitive K v channel distinct from KCNQ3, 4, or 5 limits Ca 2+ -dependent myogenic constriction, which critically determines vascular resistance in the mesenteric and renal circulations to regulate blood pressure. This K v channel is inhibited by osmotically induced cell stretch via activation of AT 1a R.
Methods

Mouse Models
Animal care followed American Physiological Society guidelines, and all protocols were locally approved. All drugs used were obtained from Sigma Aldrich (Munich, Germany) or Merck (Darmstadt, Germany). Mice were maintained in individually ventilated cages (Techniplast, Deutschland) cages under standardized conditions with an artificial 12-hour dark-light cycle, with free access to standard chow (0.25% sodium; SSNIFF Spezialitäten, Soest, Germany) and drinking water ad libitum. We studied adult (12-16 weeks old) male mice with AT 1a receptor deficiency (Agtr1a −/− ), angiotensinogen de- 22 KCNQ5 deficiency (Kcnq5 dn/dn , mice expressing a dominant negative point mutant in the pore region), 23 or double deficiency of KCNQ4 and KCNQ5 channels (Kcnq4 −/− /Kcnq5 dn/dn ). Agtr1a −/− mice 24 and Agt −/− mice 25 were backcrossed to the FVB/N genetic background (Charles River, Sulzfeld, Germany) for 8 generations and maintained in the Max Delbrück Center animal facility. Either litter-or age-matched male WT mice ( +/+ ) were used as controls. Animals were randomly assigned to the experimental procedures in accordance with the German legislation on protection of animals.
Pressurized MAs
After mice were killed, the kidneys and mesenteric bed were removed and transferred to cold (4°C), gassed (95% O 2 -5% CO 2 ) physiological salt solution. Mesenteric (third or fourth order) and renal interlobar arteries were mounted on glass cannula to allow perfusion at physiological pressures. 3, 11, 26, 27 
Isolated Perfused Kidneys
Isolated kidneys were perfused with gassed (95% O 2 -5% CO 2 ) Krebs-Henseleit solution in an organ chamber using a peristaltic pump to ensure constant flow (0.3-1.9 mL/min). Drugs (Ang II or losartan) were added to the perfusate. Perfusion pressure was measured by a pressure transducer and data recorded and analyzed by a Powerlab acquisition system (AD Instruments, Colorado Springs). Ang II-induced pressor effects were normalized to the maximal pressor effect induced by KCl (60 mmol/L). 11
Patch-Clamp Recordings
Potassium currents were recorded in the conventional whole-cell configuration of the patch-clamp technique. 29, 30 Patch pipettes (resistance, 3-5 5 MΩ) were filled with solution containing (in mmol/L) 130 KCl, 1 MgCl 2 , 3 Na 2 ATP, 0.1 Na 3 GTP, 10 HEPES, and 5 EGTA (pH, 7.2). The external solution contained (in mmol/L) 126 NaCl, 5 KCl, 1 MgCl 2 , 0.1 CaCl 2 , 11 glucose, and 10 HEPES (pH, 7.2). The hypotonic external solution contained (250 mOsm/kg; in mmol/L) 110 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 glucose, and 10 HEPES (pH, 7.4). For the corresponding normosmolar solution, mannitol was added to obtain an osmolarity of 300 mOsm/kg.
Reverse Transcription Polymerase Chain Reaction
Total RNA from brain, MAs, and renal arteries of WT mice was isolated using the RNeasy Mini Kit (QIAGEN, Valencia) and firststrand cDNA synthesis performed according to the iScriptTM cDNA Synthesis Kit (BIO-RAD, Hercules). Primer pairs and polymerase chain reaction conditions are provided in the Online Data Supplement. 
Results
AT 1a R Contribute to Vasoconstriction on Atgr1a −/− Arteries
We monitored myogenic vasoconstriction in isolated resistance-sized MAs using videomicroscopy. MA were exposed to stepwise (20 mm Hg) increases in intraluminal pressure between 20 and 100 mm Hg in the presence and absence of external Ca 2+ (1.6 mmol/L) to determine active and passive vessel diameters, respectively. Active vasoconstriction was defined as the difference between diameter in the presence and absence of external Ca 2+ at each pressure step. Figure 1 shows representative diameter recordings of MA from Agtr1a +/+ WT mice ( Figure 1A) and Agtr1a −/− mutant mice ( Figure 1B ) lacking the gene coding for AT 1a R. Progressive increases in intraluminal pressure generated active tension that counteracted further dilation at pressures >40 mm Hg in MA of Agtr1a +/+ mice, reaching peak constrictions of ≈70 μm at 80 to 100 mm Hg ( Figure 1A) . In contrast, MA of Agtr1a −/− mice lacked active vasoconstriction ( Figure 1B ), indicating that myogenic tone was nearly abolished in these arteries ( Figure 1C ). Based on an initial report that AT 1 Rs activate G q/11 protein subtypes to enact aortic contraction, 31 we compared the diameter responses to agonist stimulation of AT 1 R, α 1 -adrenoceptors, and thromboxane A 2 receptors between resistance-sized MA of Agtr1a +/+ and Agtr1a −/− mice. At an intraluminal pressure of 60 mm Hg, the α 1 -adrenoceptor agonist phenylephrine (1-100 μmol/L) and the thromboxane A 2 receptor agonist U46619 (0.01-1 μmol/L) caused strong concentration-dependent constrictions of MA from Agtr1a +/+ and Agtr1a −/− mice ( Figure 1E and 1F), thereby confirming intact G q/11 -dependent signaling. In contrast, Ang II strongly constricted arteries of Agtr1a +/+ but not Agtr1a −/− mice ( Figure 1D ), although the latter vessels fully constricted to 60 mmol/L KCl. These data confirmed the loss of functional AT 1a R in MA of Agtr1a −/− animals. In contrast, Ang II (1 μmol/L) was able to induce contraction of aortas of Agtr1a −/− mice (not shown), consistent with an earlier report that AT 1b R mediate contraction of large but not small arteries in mice. 32 We also assessed myogenic tone in cannulated renal interlobar arteries. Similar to MA, renal arteries from Agtr1a −/− mice fully constricted in response to 60 mmol/L KCl, but failed to develop pressure-dependent myogenic tone (not shown). Importantly, myogenic constriction was normal in isolated MA of Agt −/− mice lacking the angiotensinogen gene. For example, MA from Agt +/+ and Agt −/− mice showed comparable constrictor responses to 60 mmol/L KCl and dilator responses to Ca 2+ -free solution ( Figure 2 ). Notably, MA from Trpc6 −/− mice that lack the cation channel TRPC6 implicated in the myogenic response of rat cerebral arteries also showed intact myogenic tone ( Figure 3 ). Hence, our results support the concept that the AT 1a R is required for the development of myogenic vasoconstriction, but surprisingly, as revealed by Agt −/− and Trpc6 −/− arteries that retain Ca 2+ -dependent tone, myogenic responsiveness may not depend on the presence of Ang II or TRPC6 channels as surmised by earlier reports. 11, 13, 33 AT 1a R Are Essential for Pressure-Induced Responses in the Renal Circulation Next we evaluated the level of myogenic tone in the mouse renal circulation, a highly myogenic vascular bed responsible for regulating blood flow to the kidneys to influence sodium excretion and blood pressure. We calculated renal vascular resistance in isolated perfused kidneys by measuring perfusion pressure at fixed levels of flow. Online Figure IA shows that perfusion pressure increased with flow rate in kidneys of Agtr1a +/+ mice, reaching a value of ≈150 mm Hg at a flow rate of 1.9 mL/min (Online Figure IA and IC). Kidneys from Agtr1a −/− mice developed significantly less pressure at the same flow rate (Online Figure IB and IC). At 1.9 mL/min, pressure in Agtr1a −/− kidneys was ≈70 mm Hg lower than in Agtr1a +/+ kidneys. Ang II (100 nmol/L) increased perfusion pressure by ≈70 mm Hg in kidneys of Agtr1a +/+ mice, but had no effect in kidneys of Agtr1a −/− mice (Online Figure ID) , indicating that AT 1a R (but not AT 1b receptors) mediate Ang II-dependent vasoconstriction of mouse renal arterioles. We further investigated the role of the AT 1 R using the AT 1 R antagonist losartan and a Ca 2+ -free external perfusion solution. Losartan (100 nmol/L and 1 μmol/L) only slightly decreased perfusion pressure in kidneys of Agtr1a +/+ mice (Online Figure  IA and IE), but had no effect in kidneys of Agtr1a −/− mice (Online Figure IB and IE). Removal of external Ca 2+ nearly abolished flow-induced myogenic constriction in perfused kidneys of Agtr1a +/+ mice (Online Figure IA and IF) , but had no effect in kidneys of Agtr1a −/− mice (Online Figure IB and IF) . Importantly, flow-induced myogenic constriction was normal in kidneys of Agt −/− mice (Online Figure IG) . Flow-induced myogenic responsiveness also persisted in kidneys from Trpc6 −/− mice (Online Figure II) . These results demonstrate a key role of AT 1a R in the flow-induced myogenic response of the mouse renal vasculature and provide strong evidence that the contribution of AT 1a R to the renal myogenic response is independent of circulating Ang II and TRPC6 channels.
Inhibition of K v Channels by XE991 Causes Vasoconstriction
G q -protein-dependent signaling including AT 1 R activation inhibits K v 7 channels which are encoded by KCNQ genes. 17, 19, 20 Thus, we considered the alternative hypothesis that block of KCNQ channels underlies the myogenic tone initiated by mechanosensitive AT 1a R. [5] [6] [7] Because XE991 is a relatively specific inhibitor of several KCNQ subtypes, [34] [35] [36] [37] we explored whether AT 1a R suppress XE991-sensitive K + currents in freshly isolated mesenteric VSMCs (Figure 4 and Online Figure  III) . The outward K v current in WT cells was almost completely blocked by 30 μmol/L XE991 ( Figure 4A and 4B and Online Figure III) and exhibited a half-blocking concentration (IC 50 ) of ≈60 nmol/L XE991 (Online Figure IVA) , consistent with selective inhibition of KCNQ channels. XE991 (100 nmol/L) did not suppress K + current mediated by recombinant K v 1.2 or K v 1.5 channels in HEK 293 cells (Online Figure  V) , which are regarded as the major K v channels expressed by VSMCs. 38, 39 We also performed complete voltage step protocols to study the voltage-dependent properties of the XE991 and the 4-aminopyridine-sensitive current in VSMCs (Online Figure VI ). Online Figure VI shows that both drugs exhibited current inhibition over a wide range of voltages, indicating that this protocol cannot ascertain whether XE991 and 4-aminopyridine selectively block K v 7 and K v 1 channels, respectively. Consistent with earlier findings, 15 the K v current was inhibited by 100 nmol/L Ang II ( Figure 4C ), but importantly this concentration of Ang II did not inhibit the K v current in VSMCs from Agtr1a −/− mice ( Figure 4C ), and only ≈50% of the XE991-sensitive K v current component was blocked by the nonselective K v channel blocker 4-aminopyridine (2 mmol/L; Figure 4 ) that exhibited an IC 50 of ≈6 μmol/L (Online Figure IVA) . To investigate whether the K v current is mechanosensitive with an essential role of AT 1a R, the effect of osmotically induced membrane stretch (250 mOsm/kg) on VSMCs was studied. Figure 4D shows that the K v current was inhibited by hypotonicity in WT cells ( Figure 4D ), but not in VSMCs from Agtr1a −/− mice ( Figure 4D ). Consistent with its effects in cerebral arteries of rats, 5 XE991 (30 μmol/L) increased myogenic tone in mouse MA (Figure 5A and 5B) and enhanced perfusion pressure in isolated kidneys (Online Figure IVB ). XE991 at concentrations of 100 nmol/L and 30 μmol/L equi-effectively enhanced the myogenic response ( Figure 5B and Online Figure IVB) . Together, these results implicated an XE991-sensitive K v channel susceptible to AT 1 R activation as capable of limiting myogenic vasoconstriction of mouse MAs and renal arteries.
Based on pharmacological experiments using XE991, KCNQ-type K v 7 channels are proposed to modulate myogenic vasoconstriction. 5 To explore the contribution of KCNQ channels to myogenic contraction, we compared myogenic responses between isolated MA from WT mice and mice lacking activity of certain KCNQ isoforms. Because K v current in mouse mesenteric VSMCs and native KCNQ2/3 channels in neuronal cells 18 show similar high sensitivity to XE991 block, we first evaluated myogenic responsiveness in MA of Kcnq3 −/− mice. Myogenic tone and peak K v current density were normal in MA from Kcnq3 −/− mice compared with WT mice Figure VI) . Furthermore, we observed similar magnitudes of XE991sensitive K v current in freshly isolated mesenteric VSMCs from Kcnq4 −/− mice, Kcnq5 dn/dn , and Kcnq4 −/− /Kcnq5 dn/dn mice. Normalized peak K v current density also was not significantly different between VSMCs from these genotypes ( Figure 7F ). Similar to cells of WT mice, total K v currents were nearly eliminated in VSMCs isolated from all KCNQ-deficient mouse models by 30 μmol/L XE991 and 2 mmol/L 4-aminopyridine (Online Figure VII) . The XE991-sensitive K v current was resistant to the KCNQ1 channel blockers HMR1556 and chromanol 293B (Online Figure VIII) . In contrast to XE991 (Figure 5 ), the KCNQ1 channel blockers HMR1556 and chromanol 293B (each at 10 μmol/L) increased rather than decreased the diameter of pressurized MA from WT mice (Online Figure VIII) . Reverse transcription polymerase chain reaction analysis of MAs and renal arteries from WT mice revealed a KCNQ gene expression profile that included all 5 known KCNQs in MA (Online Figure IX) . However, KCNQ2 is not detected in renal arteries that show AT 1a R-dependent myogenic tone, and KCNQ1 is resistant to block by nanomolar concentrations of XE991. 34, 35 We failed to detect KCNQ2 in isolated VSMCs from mouse MA (Online Figure X) .
Discussion
Our findings provide compelling evidence that AT 1a Rs in MAs and renal arteries fulfill a fundamental physiological function by transducing intravascular pressure into the active force that underlies myogenic tone. We observed a striking loss of arterial mechanoactivation after genomic deletion of AT 1a R, but myogenic response fully persisted in the absence of angiotensinogen and after pharmacological block of AT 1 R. Our experiments rule out a major role for anticipated downstream targets of AT 1 R myogenic signaling in mesenteric and renal vessels including TRPC6 and several KCNQ channel gene families. Instead, our genetic mouse models revealed an unrecognized XE991-sensitive K + channel, which is inhibited by osmotically induced membrane stretch, requires essential involvement of AT 1a R, and limits myogenic vasoconstriction.
Various elements have been proposed to contribute to mechanosensation by VSMCs, including cell adhesion proteins, the cytoskeleton, phospholipase C, 40,41 TRPC6/TRPM4 channels, [2] [3] [4] ENaC/ASIC2 (epithelial sodium channel/acidsensing [proton-gated] ion channel 2) channels, 42 inwardly rectifying K + channels, 43 polycystins, 44 and the phospholipid bilayer of the plasma membrane. 21, [45] [46] [47] However, the primary mechanosensors involved in the myogenic response of small arteries and arterioles remain elusive. Cell stretch is able to activate AT 1 R in heterologous expression systems by an anticlockwise rotation and a shift of TM 7 into the ligand-binding pocket. 8 Such a conformational switch may also provide a structural basis for the inhibition of AT 1 R activation by inverse agonists. 8 Stretch-activation of AT 1 R also is proposed to underlie activation of TRPC6 channels by hypo-osmotic cell swelling, an effect inhibited by losartan. 11 However, the results supporting mechanosensitivity of GPCRs were obtained by heterologous overexpression of GPCRs and TRPC channels, which may have artificially accentuated their interaction. Moreover, it seems questionable whether the hypo-osmotic cell swelling used in those studies 11 faithfully (B; n=9) , Kcnq5 dn/dn (C; n=9), and Kcnq4 −/− /Kcnq5 dn/dn (D; n=10) arteries. E, Resting diameters (at 15 mm Hg) and myogenic tone at 80 mm Hg (157±9, 138±7, 145±13, 137±8 μm, respectively) were not different between the groups; P>0.05. F, Peak XE991-sensitive voltage-gated K + (K v ) currents in mesenteric vascular smooth muscle cells from wild-type, Kcnq4 −/− , Kcnq5 dn/dn , and Kcnq4 −/− /q5 dn/dn mice. Cell capacitances also were not different (22.8±0.9, 24.4±0.7, 24.6±0.9, 24.4±1.1 pF, respectively). Numbers in parentheses indicate numbers of cells tested. P>0.05. July 7, 2014 mimics stretch-dependent activation of VSMCs in situ. Thus, although cell-stretch activation of AT 1 R was inhibited by the inverse agonist losartan after heterologous overexpression, 8 we found that mechanoactivation of AT 1a R cannot be reversed by an inverse AT 1 R agonist in small arteries perfused at physiological pressures characteristic of the peripheral circulation. Additionally, we demonstrate that myogenic tone is normal in arteries of Trpc6 −/− mice, indicating that TRPC6 plays only a dispensable role in ligand-independent AT 1 R signaling in these VSMCs.
By showing that vascular preparations from Agtr1a −/− mice fail to generate normal levels of pressure-induced myogenic vasoconstriction, our work demonstrates that expression of AT 1a R is required for the myogenic response in resistance MA and in the in situ renal circulation. The vasoconstrictor response to Ang II was severely suppressed in arteries of Agtr1a −/− mice, and residual Ang II effects were attributed to AT 1b R expression. The loss of myogenic responsiveness in Agtr1a −/− mice was not caused by a deficit of Ang II-elicited signaling, because preparations from Agt −/− mice showed normal myogenic tone. Instead, our results showing normal myogenic constriction in MA of Agt −/− mice exclude the involvement of local Ang II production in myogenic tone, an inherent concern of earlier studies that relied on captopril or perindopril to rule out Ang II-dependent AT 1a R mechanosensitivity. 11, 33 Thus, we provide the most definitive evidence to date demonstrating that sustained Ang II-independent, mechanosensitive AT 1 R signaling in the arterial wall critically mediates the myogenic constriction of MAs and renal arteries. Furthermore, our findings specify the AT 1a R as the major AT 1 R subtype involved in this process. This novel GPCR signaling pathway involving AT 1a R may play an important role in blood pressure regulation, because Agtr1a −/− mice show lower systemic blood pressure (by ≈20 mm Hg) compared with WT mice, but their systolic blood pressure is similar to mice deficient in smooth muscle-specific G q/11 . 24, 31, 48 The ionic mechanism underlying AT 1a R-mediated myogenic vasoconstriction is unknown, but is presumed to rely on depolarization-induced opening of voltage-gated Ca v 1.2 channels in VSMCs. Although smooth muscle cell polycystin-1 and -2 proteins reportedly modulate the myogenic response in MAs, 44 there is no evidence that polycystin-1 and -2 are effector targets for GPCR signaling pathways. Depolarizing cation current through TRPC6/TRPM4 channels [2] [3] [4] or suppression of hyperpolarizing K + current through KCNQ-type K v channels 5 has been proposed to mediate myogenic contractions. Based on these earlier findings, we hypothesized that TRPC6 channels contribute to myogenic tone in mouse MAs and renal arteries. Surprisingly, however, we found that myogenic tone was normal in arteries of Trpc6 −/− mice, arguing against a major role for TRPC6 channels in the myogenic response to pressure. Next, we hypothesized that suppression of KCNQ channels mediates the depolarizing event downstream of AT 1a R-dependent mechanosensing that opens Ca v 1.2 channels, because the KCNQ family members are active at relatively negative membrane potentials and are inhibited by AT 1 R-activated G q -protein signaling. 17, 19, 20 Consistent with this idea, we observed that K + currents in mesenteric VSMCs were remarkably sensitive to block by XE991 at concentrations regarded as selective for KCNQ channels (IC 50 , ≈60 nmol/L) and that XE991 augmented myogenic vasoconstriction. Importantly, Ang II and osmotically induced membrane stretch suppressed the XE991-sensitive component of K v current in mesenteric VSMCs; both effects were observed in the presence of AT 1a R, but not in the absence of AT 1a R. Considering these findings, the observation of normal myogenic tone in MA from Kcnq3 −/− , Kcnq4 −/− , Kcnq5 dn/dn , and Kcnq4 −/− /Kcnq5 dn/dn mice was surprising, as was the observation that K v current was similarly blocked by XE991 in mesenteric VSMCs isolated from WT, Kcnq4 −/− , Kcnq5 dn/dn , and Kcnq4 −/− /Kcnq5 dn/dn mice. Kcnq5 dn/ dn mice 23 carry a dominant negative mutation (G278S) in the KCNQ5 pore, which renders KCNQ5 (dn)-containing homomeric channels, as well as heteromeric KCNQ5(dn)/KCNQ3 and KCNQ5(dn)/KCNQ4 channels, nonfunctional. 23 Although Kcnq1, Kcnq3, Kcnq4, and Kcnq5 gene products are widely expressed in arteries, [5] [6] [7] with KCNQ4 and 5 often being dominant, 49, 50 our data indicate that the latter 3 channel subtypes do not majorly contribute to the myogenic response in mouse MA. Nevertheless, triple-knockout mice would give a more definitive answer. It is unlikely that KCNQ1 channels are involved because native KCNQ1 channels are inhibited by XE991 with an IC 50 of ≈10 μmol/L, 34, 35 a concentration ≈100-fold higher than the one used here. In addition, the KCNQ1 channel blockers chromanol 293B and HMR1556 at a concentration (10 μmol/L) that blocks cloned KCNQ1 channels did not affect the K v current in mesenteric VSMCs, but induced an apparently off-target relaxation of MA. Additionally, we failed to detect KCNQ2 transcript in mouse renal arteries and isolated mouse mesenteric VSMCs. Other K v channels known to be expressed in VSMCs including K v 1.2/K v 1.5 and K v 2.1/K v 9.3 heteromeric channels are only blocked by higher concentrations of XE991 (10 μmol/L) than required to block K v current in mouse mesenteric VSMCs. 5 Moreover, we found that XE991 (100 nmol/L) does not alter currents attributed to recombinant K v 1.2 or K v 1.5 monomeric channels. Thus, our collective findings suggest that recognized members encoded by the K v 7 channel gene family (KCNQ3, 4, and 5 channels) are not downstream effectors of AT 1a R-initiated myogenic signaling. Instead, an unrecognized XE991-sensitive K + channel limits AT 1a R-mediated myogenic vasoconstriction. This channel also seems to serve as a novel downstream target for ligand-independent and membrane stretch-dependent AT 1a R signaling in VSMCs.
In summary, we have identified a mechanosensitive function of AT 1a R in the myogenic vasoconstriction of 2 key vascular beds. Instead of accepting the conceptual framework that multiple mechanosensitive GPCRs couple to TRPC6 channels to produce myogenic tone, 11 we propose that primarily mechanoactivated and ligand-independent AT 1a R contribute to myogenic responsiveness in VSMCs without critical involvement of TRPC6. The AT 1a R signal relies on an ion channel distinct from KCNQ3, 4, or 5. Our findings establish the foundation for additional studies designed to identify the precise mechanism of AT 1a R-mediated myogenic responsiveness, which may reveal new cellular targets for therapeutic strategies to alleviate the accentuated myogenic response that characterizes hypertension and other cardiovascular diseases. Notably, mechanoactivation of AT 1 R is also proposed to contribute to pressure overload-induced cardiac hypertrophy. 51 Hypertrophic effects were observed in Agt −/− mice 51 and were reversed by the inverse AT 1 R agonist candesartan, suggesting that the hypertrophic effects are caused by AT 1 R activation induced by mechanical stress independently of Ang II. 51 However, the interpretation of these results is not straightforward because other strong inverse agonists such as valsartan 52 did not blunt the development of hypertrophy, 53 and mechanical stretch can induce hypertrophic responses in cardiac myocytes of AT 1a R knockout mice. 54 Regardless, the precise contribution of ligand-independent, AT 1a R-induced mechanosignaling to cellular processes previously attributed to Ang II may be revealed by future studies as pathogenic events underlying diverse and numerous cardiovascular diseases.
What Is Known?
• Stretch imposed on the vascular wall by intravascular pressure mediates a contractile or a myogenic response to maintain blood flow despite fluctuations in perfusion pressure. • Osmotically induced cell stretch initiates a conformational switch in the angiotensin II type 1 receptor (AT 1 R) to cause ligand-independent receptor activation in heterologous expression systems. • Mechanosensitive G protein-coupled receptors, including AT 1 R, have been implicated as mediators of myogenic responsiveness through ligand-independent signaling and G q/11 -protein activation of TRPC6 channels.
What New Information Does This Article Contribute?
• Our findings provide the first definitive evidence that the AT 1 R subtype a (AT 1a R) is the major AT 1 R subtype in vascular smooth muscle cells (VSMCs), which can elicit myogenic constriction of mouse mesenteric and renal resistance arteries in the absence of its native ligand, angiotensin II. • Our experiments indicate that the predicted downstream targets of AT 1 Relicited myogenic signaling in mouse mesenteric and renal arteries including TRPC6 and several KCNQ channel gene families do not majorly contribute to the myogenic response to rises in intraluminal pressure. • Our results reveal an unrecognized XE991-sensitive K + channel in VSMCs that is inhibited by osmotic membrane stretch as a potential mediator of AT 1a R-elicited myogenic vasoconstriction.
A definitive role for G protein-coupled receptors as ligandindependent mechanosensors in VSMCs is not firmly established, and the downstream effectors that mediate stretch-induced depolarization are unknown. We find a striking loss of pressureinduced myogenic contraction after gene deletion of AT 1a R in mouse mesenteric and renal resistance arteries, but the myogenic response fully persists in the absence of angiotensinogen or after pharmacological block of AT 1 R. Instead of accepting the concept that multiple mechanosensitive G protein-coupled receptors couple to TRPC6 channels to mediate myogenic tone, we propose that primarily mechanoactivated and ligandindependent AT 1a R contribute to myogenic responsiveness in VSMCs without critical involvement of TRPC6. The AT 1a R signal relies on an ion channel distinct from KCNQ3, 4, or 5 to depolarize VSMCs. We provide new evidence that a voltage-gated K + channel in mesenteric VSMCs is activated by osmotic stretch, and this response requires the expression of AT 1a R. Our findings establish the foundation for additional studies designed to identify the precise mechanism of AT 1a R-mediated myogenic responsiveness, which may involve a previously unrecognized XE991-sensitive voltage-gated K + channel distinct from KCNQ3, 4, or 5 as a therapeutic target to alleviate anomalous myogenic tone.
Novelty and Significance
